Why chemotherapy can fail?

• Published in: Polish journal of veterinary sciences Vol. 13; no. 2; pp. 399 - 406
• Main Authors: Król, M, Pawłowski, K M, Majchrzak, K, Szyszko, K, Motyl, T
• Format: Journal Article
• Language: English
• Published: Germany Polish Academy of Sciences, Committee of Veterinary Sciences 01.01.2010
• Subjects: Animals; Antineoplastic Agents - therapeutic use; Drug Resistance, Neoplasm; Humans; Neoplasms - drug therapy; Neoplasms - veterinary; Treatment Failure
• ISSN: 1505-1773; 2300-2557

There are many reasons that lead to failure of cancer chemotherapy. Cancer has the ability to become resistant to many different types of drugs. Increased efflux of drug, enhanced repair/increased tolerance to DNA damage, high antiapoptotic potential, decreased permeability and enzymatic deactivation allow cancer cell survive the chemotherapy. Treatment can lead to the death of most tumor cells (drug-sensitive), but some of them (drug-resistant) survive and grow again. These tumor cells may arise from stem cells. There are many studies describing human experiments with multidrug resistance, especially in breast cancer. Unfortunately, studies of canine or feline ABC super family members are not as extensive as in human or mice and they are limited to several papers describing PGP in mammary cancer, cutaneous mast cell tumors and lymphoma. Multidrug resistance is one of the most significant problems in oncology today. The involvement of many different, not fully recognized, mechanisms in multidrug resistance of cancer cells makes the development of effective methods of therapy very difficult. Understanding the mechanisms of drug resistance in cancer cells may improve the results of treatment. This review article provides a synopsis of all aspects that refer to cancer cell resistance to antitumor drugs.